Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

HNI Corp (HNI): The Key to Growth for Herman Miller, Inc. (MLHR) Earnings

Herman Miller, Inc. (NASDAQ:MLHR) will release its quarterly report on Wednesday, but investors haven’t been too sure of the company’s likely future direction. The stock has done well so far this year, but has come off its recent highs, and Herman Miller, Inc. (NASDAQ:MLHR) earnings are expected to come in flat from year-ago levels.

Herman Miller, Inc. (NASDAQ:MLHR)

Herman Miller, Inc. (NASDAQ:MLHR) specializes in office furniture, with its Aeron chair being a longtime standard of ergonomic design. As businesses cut back on spending during and after the financial crisis, the business-equipment maker went through relatively tough times. As corporate America starts to bounce back more convincingly, though, will customers start spending on Herman Miller’s products again? Let’s take an early look at what’s been happening with Herman Miller, Inc. (NASDAQ:MLHR) over the past quarter, and what we’re likely to see in its report.

Stats on Herman Miller

Analyst EPS Estimate $0.38
Change From Year-Ago EPS 0%
Revenue Estimate $465.1 million
Change From Year-Ago Revenue 3.4%
Earnings Beats in Past 4 Quarters 2

Source: Yahoo! Finance.

Can Herman Miller earnings keep moving higher this quarter?
Analysts have marked down their expectations for Herman Miller earnings in recent months, cutting $0.08 per share from their August-quarter estimates, and a similar amount from their full-year fiscal 2014 projections. The stock has largely been stuck in a holding pattern, having fallen 6% since mid-June, and consolidating gains from earlier in the year.

One reason for Herman Miller, Inc. (NASDAQ:MLHR)’s recent struggles became apparent in its May-quarter report, in which the company reported sharply higher earnings on a 9.3% jump in quarterly revenue. But looking forward, the company’s guidance fell well short of what investors had hoped to see. CEO Brian Walker specifically mentioned sequestration as holding back government spending, and contributing to sluggishness in the industry.

Still, improvements in economic conditions should help Herman Miller’s business going forward. After plunging in late 2008 and early 2009, business-spending levels have risen to new highs recently, suggesting that companies are making long-delayed capital expenditures. Rival HNI Corp (NYSE:HNI), which makes fireplace products as well as office furniture, has been more optimistic about prospects for the industry. HNI Corp (NYSE:HNI) has the advantage of exposure to the housing market through its hearth-products segment, but even though cutbacks in government spending have offset some private-sector gains, macroeconomic factors could start working in Herman Miller’s favor.

Another potential threat comes from competitor innovation. Steelcase Inc. (NYSE:SCS) recently came out with its Gesture chair, which offers ergonomically appealing functionality for an array of different activities, including typing, presenting via tablet, or using other devices. As technology continues to advance, Herman Miller, Inc. (NASDAQ:MLHR) needs to make sure it doesn’t fall behind the rest of its industry peers.

In the Herman Miller earnings report, watch to see how the company expects to launch new products in the future. Continuing to produce the same quality products that built its reputation in the first place will be crucial in Herman Miller’s effort to continue its track record of success.

The article The Key to Growth for Herman Miller Earnings originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!